Global Molecular Quality Controls Market to Reach $286.9 Million by 2030
The global market for Molecular Quality Controls estimated at US$214.9 Million in the year 2022, is projected to reach a revised size of US$286.9 Million by 2030, growing at a CAGR of 3.7% over the analysis period 2022-2030. Independent Controls, one of the segments analyzed in the report, is projected to record 4.2% CAGR and reach US$190.3 Million by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Instrument-Specific Controls segment is readjusted to a revised 2.7% CAGR for the next 8-year period.The U.S. Market is Estimated at $62.9 Million, While China is Forecast to Grow at 3.2% CAGR
The Molecular Quality Controls market in the U.S. is estimated at US$62.9 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$50 Million by the year 2030 trailing a CAGR of 3.2% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.2% and 2.2% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 2.3% CAGR.Select Competitors (Total 33 Featured) -
- Abbott Laboratories
- Bio-Rad Laboratories, Inc.
- Danaher
- F. Hoffmann-La Roche Ltd
- Helena Biosciences Europe
- Maine Molecular Quality Controls, Inc.
- Microbiologics, Inc.
- Qnostics
- Quidel Corporation
- Randox Laboratories Ltd.
- SeraCare Life Sciences, Inc.
- SERO AS
- Technopath Clinical Diagnostics
- Thermo Fisher Scientific Inc.
- ZeptoMetrix Corporation
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its 'bumpy' reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERSIII. MARKET ANALYSISCANADAITALYREST OF EUROPEREST OF WORLDIV. COMPETITION
1. MARKET OVERVIEW
4. GLOBAL MARKET PERSPECTIVE
UNITED STATES
JAPAN
CHINA
EUROPE
FRANCE
GERMANY
UNITED KINGDOM
ASIA-PACIFIC
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Laboratories
- Bio-Rad Laboratories, Inc.
- Danaher
- F. Hoffmann-La Roche Ltd
- Helena Biosciences Europe
- Maine Molecular Quality Controls, Inc.
- Microbiologics, Inc.
- Qnostics
- Quidel Corporation
- Randox Laboratories Ltd.
- SeraCare Life Sciences, Inc.
- SERO AS
- Technopath Clinical Diagnostics
- Thermo Fisher Scientific Inc.
- ZeptoMetrix Corporation
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 89 |
Published | April 2024 |
Forecast Period | 2022 - 2030 |
Estimated Market Value ( USD | $ 214.9 Million |
Forecasted Market Value ( USD | $ 286.9 Million |
Compound Annual Growth Rate | 3.7% |
Regions Covered | Global |